Abstract:Epilepsy is a chronic neurological disorder characterized by recurrent seizures. Despite various treatment approaches, a significant number of patients continue to experience uncontrolled seizures, leading to refractory epilepsy. The emergence of novel anti-epileptic drugs, such as perampanel (PER), has provided promising options for effective epilepsy treatment. However, the specific mechanisms underlying the therapeutic effects of PER remain unclear. This study aimed to investigate the intrinsic molecular regulatory mechanisms involved in the downregulation of GluA2, a key subunit of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, following epileptic seizures. Primary mouse hippocampal neurons were cultured and subjected to an epilepsy cell model. The expression levels of GluA2 and autophagy-related proteins were assessed using Western blotting and real-time fluorescent quantitative PCR. Immunofluorescence and immunohistochemistry techniques were employed to investigate the nuclear translocation of CREB-regulated transcriptional coactivator 1 (CRTC1). Additionally, status epilepticus animal models were established to further validate the findings. The epilepsy cell model exhibited a significant decrease in GluA2 expression, accompanied by elevated levels of autophagy-related proteins. Immunofluorescence analysis revealed the nuclear translocation of CRTC1, which correlated with the expression of autophagy-related genes. Treatment with an autophagy inhibitor reversed the decreased expression of GluA2 in the epilepsy cell model. Furthermore, the calcium/calmodulin-dependent protein phosphatase inhibitor FK506 and CaN overexpression affected the dephosphorylation and nuclear translocation of CRTC1, consequently influencing GluA2 expression. Animal model results further supported the involvement of these molecular mechanisms in epilepsy. Our findings suggest that the downregulation of GluA2 following epileptic seizures involves the activation of autophagy and the regulation of CRTC1 nuclear translocation. These intrinsic molecular regulatory mechanisms provide potential targets for developing novel therapeutic strategies to alleviate refractory epilepsy and preserve cognitive functions in patients.

Effects of immunoregulation on immunoreaction of glutamate and PKC in neurons and microglia of rats with epilepsy

Effect of diazoxide on regulation of vesicular and plasma membrane GABA transporter genes and proteins in hippocampus of rats subjected to picrotoxin-induced kindling.

Changes in the gene and protein expression of KATP channel subunits in the hippocampus of rats subjected to picrotoxin-induced kindling

Activation of microglia in rat model of epilepsy during persistent state and analysis of temporal and spatial expression of different types of microglia

Altered Glutamate Metabolism Contributes to Antiepileptogenic Effects in the Progression from Focal Seizure to Generalized Seizure by Low-Frequency Stimulation in the Ventral Hippocampus

Effects of Immunoglobulin on GABA Receptors and Expression of GAD in Epileptic Rats

Effects of Ganoderma Lucidum Spores on Expression of PSA‐NCAM and Hippocampus Mossy Fiber Sprouting in Pentylenetetrazol‐induced Epileptic Rats

Targeting microglial GLP1R in epilepsy: A novel approach to modulate neuroinflammation and neuronal apoptosis

[C-Fos Expression in the Hippocampus of Rats with Pentylenetetrazol-Induced Epilepsy]

Alterations of NR2B and PSD-95 expression after early-life epileptiform discharges in developing neurons.

Microglia PKM2 Mediates Neuroinflammation and Neuron Loss in Mice Epilepsy through the Astrocyte C3-Neuron C3R Signaling Pathway

Investigating the Effects of Perampanel on Autophagy-mediated Regulation of GluA2 and PSD95 in Epilepsy

Grouping Pentylenetetrazol-Induced Epileptic Rats According to Memory Impairment and MicroRNA Expression Profiles in the Hippocampus

Effects of Ganleroma Lucidum Spores on the Apoptosis of Brain Neurons and the Expression of Brain IGF‐1 and NF‐κB in the Epilepsy Rat

IRAK-M Ablation Promotes Status Epilepticus-Induced Neuroinflammation via Activating M1 Microglia and Impairing Excitatory Synaptic Function

A study on the protective mechanism of mTOR inhibitor Everolimus on brain injury after epilepsy

The effect of IL-1β on synaptophysin expression and electrophysiology of hippocampal neurons through the PI3K/Akt/mTOR signaling pathway in a rat model of mesial temporal lobe epilepsy

The Effects of Antiepileptic Drugs on Spatial Alteration Learning and Brain Protein Kinase Cγ in Premature Rats

Microglial depletion aggravates the severity of acute and chronic seizures in mice

[Protection of Interleukin-1 Receptor Antagonist on Epileptiform Discharges Induced by Magnesium-Free Treatment in Developing Rat Cortical Neurons].

NMDA receptor function is enhanced in the cerebral cortex and hippocampus of genetically epilepsy-prone rat